Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Revenue

Zeria Pharmaceutical had revenue of 20.47B JPY in the quarter ending September 30, 2025, a decrease of -2.37%. This brings the company's revenue in the last twelve months to 84.85B, up 4.15% year-over-year. In the fiscal year ending March 31, 2025, Zeria Pharmaceutical had annual revenue of 87.31B with 15.30% growth.

• Revenue (ttm): 84.85B
• Revenue Growth: +4.15%
• P/S Ratio: 1.07
• Revenue / Employee: 48.60M
• Employees: 1,746
• Market Cap: 91.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	87.31B	11.59B	15.30%
Mar 31, 2024	75.73B	7.34B	10.74%
Mar 31, 2023	68.38B	8.85B	14.87%
Mar 31, 2022	59.53B	4.09B	7.38%
Mar 31, 2021	55.44B	-4.98B	-8.25%